DIAGNOSIS, PROGNOSTICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) IN DAILY PRACTICE: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY

被引：0
|
作者：
Dinmohamed, A. [1 ]
Visser, O. [2 ]
Posthuma, W. [3 ]
Huijgens, P. [2 ,4 ]
Sonneveld, P. [1 ]
van de Loosdrecht, A. [4 ]
Jongen-Lavrencic, M. [1 ]
机构：
[1] Erasmus MC Canc Inst, Hematol, Rotterdam, Netherlands
[2] Comprehens Canc Ctr Netherlands, Registrat & Res, Utrecht, Netherlands
[3] Reinier de Graaf Grp, Internal Med, Delft, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Hematol, Amsterdam, Netherlands
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1216
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [1] Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry
    Dinmohamed, A. G.
    van Norden, Y.
    Visser, O.
    Posthuma, E. F. M.
    Huijgens, P. C.
    Sonneveld, P.
    van de Loosdrecht, A. A.
    Jongen-Lavrencic, M.
    LEUKEMIA, 2015, 29 (12) : 2449 - 2451
  • [2] Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry
    A G Dinmohamed
    Y van Norden
    O Visser
    E F M Posthuma
    P C Huijgens
    P Sonneveld
    A A van de Loosdrecht
    M Jongen-Lavrencic
    Leukemia, 2015, 29 : 2449 - 2451
  • [3] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) in outpatient clinics - results of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Welslau, M.
    Lerchenmueller, C.
    Sauer, A.
    Germing, U.
    ONKOLOGIE, 2011, 34 : 289 - 289
  • [4] CLINICAL FEATURES, TREATMENT DECISIONS AND TREATMENT OUTCOMES OF PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) IN THE REAL-WORLD: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY
    Dinmohamed, A.
    Visser, O.
    Posthuma, W.
    Wegman, J.
    van Esser, J.
    Mattijssen, V.
    Klein, S.
    Wijermans, P.
    Kooy, M. van Marwijk
    Huls, G.
    Huijgens, P.
    de Greef, I.
    Sonneveld, P.
    van de Loosdrecht, A.
    Jongen-Lavrencic, M.
    HAEMATOLOGICA, 2015, 100 : 486 - 486
  • [5] Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register
    Berggren, Daniel Moreno
    Folkvaljon, Yasin
    Engvall, Marie
    Sundberg, Johan
    Lambe, Mats
    Antunovic, Petar
    Garelius, Hege
    Lorenz, Fryderyk
    Nilsson, Lars
    Rasmussen, Bengt
    Lehmann, Soren
    Hellstrom-Lindberg, Eva
    Jadersten, Martin
    Ejerblad, Elisabeth
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (05) : 614 - 627
  • [6] Diagnostic procedures and treatment of patients with myelodysplastic syndromes (MDS) in outpatient clinics. Results of the outpatient MDS registry
    Schmitz, S.
    Boettger, I.
    Schnell, R.
    Sauer, A.
    Linde, H.
    Severin, K.
    Germing, U.
    Steinmetz, T.
    LEUKEMIA RESEARCH, 2013, 37 : S115 - S115
  • [7] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) - update of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Sauer, A.
    Buschmann, D.
    Germing, U.
    Severin, K.
    Steinmetz, H. T.
    ONKOLOGIE, 2013, 36 : 242 - 242
  • [8] CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES (MDS) IN DAILY PRACTICE: A POPULATION-BASED STUDY AMONG 8912 PATIENTS DIAGNOSED IN THE NETHERLANDS FROM 2001 TO 2014
    Dinmohamed, A.
    Visser, O.
    Jongen-Lavrencic, M.
    van de Loosdrecht, A.
    HAEMATOLOGICA, 2016, 101 : 244 - 245
  • [9] EFFECTIVENESS OF AZACITIDINE COMPARED TO CONVENTIONAL CARE REGIMENS FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASIA IN THE REAL-WORLD: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY
    Dinmohamed, A.
    Visser, O.
    Posthuma, W.
    Hoogendoorn, M.
    Mattijssen, V.
    Wegman, J.
    Koene, H.
    Kooy, M. van Marwijk
    Klein, S.
    Sinnige, H.
    van Esser, J.
    Wijermans, P.
    Huls, G.
    Huijgens, P.
    Sonneveld, P.
    van de Loosdrecht, A.
    Jongen-Lavrencic, M.
    HAEMATOLOGICA, 2015, 100 : 484 - 485
  • [10] Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry
    Steinmetz, H. T.
    Boettger, I
    Lathan, B.
    Sauer, A.
    Severin, K.
    Germing, U.
    Schmitz, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 234 - 234
12345